Literature DB >> 11586364

Quality control of mRNA 3'-end processing is linked to the nuclear exosome.

P Hilleren1, T McCarthy, M Rosbash, R Parker, T H Jensen.   

Abstract

An emerging theme in messenger RNA metabolism is the coupling of nuclear pre-mRNA processing events, which contributes to mRNA quality control. Most eukaryotic mRNAs acquire a poly(A) tail during 3'-end processing within the nucleus, and this is coupled to efficient export of mRNAs to the cytoplasm. In the yeast Saccharomyces cerevisiae, a common consequence of defective nuclear export of mRNA is the hyperadenylation of nascent transcripts, which are sequestered at or near their sites of transcription. This implies that polyadenylation and nuclear export are coupled in a step that involves the release of mRNA from transcription site foci. Here we demonstrate that transcripts which fail to acquire a poly(A) tail are also retained at or near transcription sites. Surprisingly, this retention mechanism requires the protein Rrp6p and the nuclear exosome, a large complex of exonucleolytic enzymes. In exosome mutants, hypo- as well as hyperadenylated mRNAs are released and translated. These observations suggest that the exosome contributes to a checkpoint that monitors proper 3'-end formation of mRNA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11586364     DOI: 10.1038/35097110

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  166 in total

1.  T7 RNA polymerase-directed transcripts are processed in yeast and link 3' end formation to mRNA nuclear export.

Authors:  Ken Dower; Michael Rosbash
Journal:  RNA       Date:  2002-05       Impact factor: 4.942

2.  PNPase activity determines the efficiency of mRNA 3'-end processing, the degradation of tRNA and the extent of polyadenylation in chloroplasts.

Authors:  Michael Walter; Joachim Kilian; Jörg Kudla
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

3.  Intron status and 3'-end formation control cotranscriptional export of mRNA.

Authors:  Elissa P Lei; Pamela A Silver
Journal:  Genes Dev       Date:  2002-11-01       Impact factor: 11.361

4.  The human core exosome interacts with differentially localized processive RNases: hDIS3 and hDIS3L.

Authors:  Rafal Tomecki; Maiken S Kristiansen; Søren Lykke-Andersen; Aleksander Chlebowski; Katja M Larsen; Roman J Szczesny; Karolina Drazkowska; Agnieszka Pastula; Jens S Andersen; Piotr P Stepien; Andrzej Dziembowski; Torben Heick Jensen
Journal:  EMBO J       Date:  2010-06-08       Impact factor: 11.598

5.  A role for the exosome in the in vivo degradation of unstable mRNAs.

Authors:  Simon Haile; Antonio M Estevez; Christine Clayton
Journal:  RNA       Date:  2003-12       Impact factor: 4.942

6.  Evidence that poly(A) binding protein has an evolutionarily conserved function in facilitating mRNA biogenesis and export.

Authors:  Julia A Chekanova; Dmitry A Belostotsky
Journal:  RNA       Date:  2003-12       Impact factor: 4.942

7.  Contribution of domain structure to the RNA 3' end processing and degradation functions of the nuclear exosome subunit Rrp6p.

Authors:  Seasson Phillips; J Scott Butler
Journal:  RNA       Date:  2003-09       Impact factor: 4.942

8.  Turnover of primary transcripts is a major step in the regulation of mouse H19 gene expression.

Authors:  Laura Milligan; Thierry Forné; Etienne Antoine; Michaël Weber; Bénédicte Hémonnot; Luisa Dandolo; Claude Brunel; Guy Cathala
Journal:  EMBO Rep       Date:  2002-07-15       Impact factor: 8.807

9.  Nuclear pre-mRNA decapping and 5' degradation in yeast require the Lsm2-8p complex.

Authors:  Joanna Kufel; Cecile Bousquet-Antonelli; Jean D Beggs; David Tollervey
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

10.  Rrp47p is an exosome-associated protein required for the 3' processing of stable RNAs.

Authors:  Philip Mitchell; Elisabeth Petfalski; Rym Houalla; Alexandre Podtelejnikov; Matthias Mann; David Tollervey
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.